Cerebellar liponeurocytoma is morphologically composed of uniform round cells with neuronal differentiation and lipomatous features. It typically affects adults and has a favourable prognosis. Initially described as a lipomatous medulloblastoma, the World Health Organisation Working group proposes the term “cerebellar liponeurocytoma” primarily to distinguish this entity from medulloblastoma and to avoid over treatment of this benign tumor. Here, we report to the best of our knowledge the second case in the literature of cerebellar liponeurocytoma with myoid features and discuss the histogenesis of this rare tumor.
The patient was a 52-year-old man who presented with a 4-month history of headache of gradual onset, vomiting and decreased visual acuity. His past medical and family history were unremarkable. Neurological examination revealed cerebellar syndrome. Magnetic resonance imaging (MRI) showed a relatively well-defined, poorly enhancing, round lesion in the left cerebellar hemisphere hyperintense on T2-Weighted Images, causing moderate mass effect [Figure1]. At surgery, a 5,7cm x 4,7cm, well circumscribed mass, located in the cerebellar left hemisphere was removed.
Ten percent formalin-fixed specimens were paraffin-embedded, cut at 3 µm, and stained with eosin-hematoxylin-saffron.
Microscopically, the tumor was composed of small round cells to polygonal with eosinophilic or clear cytoplasm resembling oligodendrocytes [Figure 2]. In some areas, the tumor cells were mixed with lipomatous cells [Figure 3] and myocyte-like cells [Figure 4]. The tumor shows no mitotic figures.
An immunohistochemical study was performed. After heat-induced epitope retrieval, dewaxed 3µm sections were incubated with the following antibodies: synaptophysin (Cell Marque, Rabbit polyclonal), GFAP (glial fibrillary acidic protein) (Cell Marque, Clone G-A-5, Mouse monoclonal), Mib1 (Cell Marque, Clone sp6, Rabbit monoclonal) and desmin (Cell Marque, clone D33, Mouse monoclonal). Revelation was performed after a streptavidin-biotin-peroxidase technique with diaminobenzidine.
Tumour cells expressed synaptophysin [Figure 5], GFAP [Figure 6] and focally desmin [Figure 7]. The Mib 1 antibody stained less than 1% of tumour cell nuclei. The tumor was classified as a cerebellar liponeurocytoma with myoid differentiation grade II accordind to the WHO grading.
Her postoperative period was uneventful with no evidence of tumour recurrence after 12 months.
Liponeurocytoma is a rare cebellar neoplasm of adults that is histologically characterized by neuronal differentiation with focal lipidization and low proliferative potential.
Since the first report  by Bechtel in 1978 as a mixed mesenchymal and neuroectodermal tumor of the cerebellum, several terms “medullocytoma” , “lipomatous glioneurocytoma” and “lipidized mature neuroectodermal tumor of the cerebellum”  have been proposed as to emphasize its resemblance to central neurocytoma.
In 2000 , the WHO classification of tumours of the central nervous system proposed the term “cerebellar liponeurocytoma” to distinguish this tumor from medulloblastoma because of the outcome and to avoid aggressive treatment to this benign tumor.
This tumor classically manifests at the fifth decades like our case (mean 50 years)  without significant gender predilection. This is in contrast with the age distribution of medulloblastoma. The clinical features are non-specific.
This tumour is predominantly located in the cerebellar hemispheres like our observation followed by the vermis.
Histologically, the cerebellar liponeurocytoma features a monotonous pattern of round cells with focal lipidization and neuronal differenciation reflected by immunoreactivity to neuronal markers . The Mib1labelling index is even lower.
In the literature data, only one case has been reported with additional immunoreactivity to desmin  in a 67 year-old woman. This myogenic feature hasn’t anysignificance.
The most important differential diagnosis is medulloblastoma but the occurrence of the latter in children and the high Mib-1 labelling index can distinguish between these two tumors.
The histogenesis of cerebellar liponeurocytoma has remained unclear. The immunoreactivity to neuronal antigens suggests that the fat containing cells result from lipomatous differentiation of tumour cells. The cell of origin is a precursor cell with commitment to neuronal differentiation but a capacity for divergent astrocytic and myogenic differentiation.
Some studies suggests that this tumor is derived from the external granular layer of the cerebellum.  Several genetics studies suggests that medulloblastoma are distinctly different from liponeurocytoma  with particular higher frequency mutation of TP53 in liponeurocytoma than in medulloblastoma.
A complete surgical resection is recommended as the initial treatment but there is no consensus regarding the treatment of this rare tumor specifically adjuvant chemo-or radiotherapy. The prognosis of liponeurocytoma is favourable 
In conclusion, the cerebellar liponeurocytoma is a histopathologically and genetically distinct entity. The distinction between liponeurocytoma and medulloblastoma is very important since the medulloblastoma requires adjuvant radio/chemotherapy.